Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction
about
Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regenerationReprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?Strategies and Challenges to Myocardial Replacement TherapyMass spectrometry-based secretome analysis of non-small cell lung cancer cell lines.Macrophages in Tissue Repair, Regeneration, and Fibrosis.Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease.Emerging roles for macrophages in cardiac injury: cytoprotection, repair, and regenerationAnalysis of the Secretome of Apoptotic Peripheral Blood Mononuclear Cells: Impact of Released Proteins and Exosomes for Tissue Regeneration.Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.Development and Function of Arterial and Cardiac Macrophages.The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations.Increased plasma VEGF levels following ischemic preconditioning are associated with downregulation of miRNA-762 and miR-3072-5pOverexpression of DNMT3b target genes during Enteric Nervous System development contribute to the onset of Hirschsprung diseaseTargeting Amino Acid Metabolism for Molecular Imaging of Inflammation Early After Myocardial Infarction.Choroid plexus-cerebrospinal fluid route for monocyte-derived macrophages after stroke.Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells.Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles.Cell secretome based drug substances in regenerative medicine: when regulatory affairs meet basic science.Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application.Safety Evaluation of Sevoflurane as Anesthetic Agent in Mouse Model of Myocardial Ischemic Infarction.Quantification of small GTPase glucosylation by clostridial glucosylating toxins using multiplexed MRM analysis.
P2860
Q26765166-14AA8A5E-9307-4E69-A4F1-93C978AC8360Q26800082-1B05F93E-27EB-42FB-B2CE-346E4D19EB2DQ28068007-CA4A9BDB-10B9-4A68-B22B-D5FE808A1537Q30313775-7EC3E5C2-1A3D-4593-BF20-FF57FFCF48D8Q34518415-119F917E-DDFE-4E04-A078-B5FBBF3B0B4FQ34531894-B1E06A47-D561-4C8C-9D59-CFBE6886B968Q36040543-61E09CBB-AC51-4A82-ABE5-1BDFD7CD3845Q36280879-346E20D1-F574-41AF-842A-3881BAC19E3CQ36353619-EA54D955-64F8-49D4-81BB-9721B67D2E78Q38560476-7B6E812B-32FC-4C67-B089-505A5EE96795Q38691116-DF935F8D-335F-46E0-B9F7-B593C30C29F5Q38875774-9FC690CD-8778-496E-BCDE-45E16F908D23Q39128194-87DA7B92-5D6C-45A0-BF64-B6BA7013F425Q39140242-0DBAC064-AB05-4F20-BE3F-F5B319ACFF0EQ41109493-58ABF537-0A86-4C1F-BD1A-6404C09E98DBQ41212276-72AEE8C6-8C3E-4B27-BC06-E771830D9F2AQ41834713-8301CB0F-31A1-4F27-B702-47C9A98A2D40Q42010694-8BE9E606-005A-464F-901A-6A43A6AEF5E8Q42044067-B8A74397-EACD-4CA8-B61C-EE83408318B4Q42359770-C87187C0-368A-4C50-84CD-5E1E4C244773Q47270959-8EE3C2A9-30E6-49DF-BB38-712347460816Q47444590-B308052B-233F-4589-8826-09A89D7F2AB2Q51115491-0B141804-8028-4DB2-8252-87A0B10E7860
P2860
Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Myeloid-derived growth factor ...... ollowing myocardial infarction
@ast
Myeloid-derived growth factor ...... ollowing myocardial infarction
@en
Myeloid-derived growth factor ...... ollowing myocardial infarction
@en-gb
Myeloid-derived growth factor ...... ollowing myocardial infarction
@nl
type
label
Myeloid-derived growth factor ...... ollowing myocardial infarction
@ast
Myeloid-derived growth factor ...... ollowing myocardial infarction
@en
Myeloid-derived growth factor ...... ollowing myocardial infarction
@en-gb
Myeloid-derived growth factor ...... ollowing myocardial infarction
@nl
prefLabel
Myeloid-derived growth factor ...... ollowing myocardial infarction
@ast
Myeloid-derived growth factor ...... ollowing myocardial infarction
@en
Myeloid-derived growth factor ...... ollowing myocardial infarction
@en-gb
Myeloid-derived growth factor ...... ollowing myocardial infarction
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Myeloid-derived growth factor ...... ollowing myocardial infarction
@en
P2093
Andreas Pich
Antonio Iglesias
Arnold Ganser
Eva Brinkmann
Felix Polten
Hans W Niessen
Hans-Joachim Schönfeld
Ines Reimann
Jacques Mizrahi
Johann Bauersachs
P2860
P2888
P304
P3181
P356
10.1038/NM.3778
P407
P577
2015-02-01T00:00:00Z
P5875
P6179
1036270015